We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01250925
Previous Study | Return to List | Next Study

Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01250925
First Posted: December 1, 2010
Last Update Posted: January 10, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of Iowa
Alcon Research
Information provided by (Responsible Party):
Massachusetts Eye and Ear Infirmary
  Purpose
The purpose of this study is to utilize in-vivo confocal microscopy to describe differences in corneal epithelial immune status across three lens care regimens in new contact lens wearers.

Condition Intervention Phase
Myopia Refractive Error Drug: ReNu MultiPlus® MultiPurpose Solution Drug: OPTI-FREE® RepleniSH® Drug: Clear Care® Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Supportive Care
Official Title: Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface: A Laser In Vivo Confocal Microscopy Study

Resource links provided by NLM:


Further study details as provided by Massachusetts Eye and Ear Infirmary:

Primary Outcome Measures:
  • Corneal Epithelial Immune Dendritic Cell Density (Central Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.

  • Corneal Epithelial Immune Dendritic Cell Density (Inferior Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.

  • Corneal Epithelial Immune Dendritic Cell Density (Nasal Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.

  • Corneal Epithelial Immune Dendritic Cell Density (Superior Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.

  • Corneal Epithelial Immune Dendritic Cell Density (Temporal Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.

  • Corneal Epithelial Immune Non-Dendritic Cell Density (Central Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.

  • Corneal Epithelial Immune Non-Dendritic Cell Density (Inferior Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.

  • Corneal Epithelial Immune Non-Dendritic Cell Density (Nasal Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.

  • Corneal Epithelial Immune Non-Dendritic Cell Density (Superior Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.

  • Corneal Epithelial Immune Non-Dendritic Cell Density (Temporal Cornea) [ Time Frame: Six weeks ]
    The primary statistical objective is to describe differences in efficacy between regimens, specifically for measures of epithelial immune status. Immune status will be assessed via density of dendritic and non-dendritic immune cells.


Secondary Outcome Measures:
  • Number of Participants With Slit-lamp Findings, Corrected Visual Acuity (Snellen) and Adverse Events [ Time Frame: Six weeks ]
    The safety analysis will be based on slit-lamp findings, corrected visual acuity (Snellen) and adverse events (if any). No inferential statistical analyses are planned for any safety variable.


Enrollment: 94
Study Start Date: August 2010
Study Completion Date: July 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: OPTI-FREE® RepleniSH®
33 participants will be assigned to use this lens care regimen during the six-week assessment period
Drug: OPTI-FREE® RepleniSH®
Contact Lens care regimen
Active Comparator: Clear Care®
33 participants will be assigned to use this lens care regimen during the six-week assessment period
Drug: Clear Care®
Contact lens care regimen
Active Comparator: ReNu MultiPlus® MultiPurpose Solution
33 participants will be assigned to use this lens care regimen during the six-week assessment period
Drug: ReNu MultiPlus® MultiPurpose Solution
Contact lens care regimen

Detailed Description:
An estimated 40 million people in the United States wear contact lenses, with approximately 38 million soft lens wearers and 2 million rigid gas permeable lens wearers. The ocular surface has been shown to respond to the introduction of foreign materials with upregulation of proinflammatory mediators, leading to an increase in inflammation. The corneal can show a foreign body immune response to contact lenses. The purpose of this study is to utilize in-vivo confocal microscopy to describe differences in corneal epithelial immune status across the three lens care regimens in new contact lens wearers.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Subjects must be 18 years of age and may be of any race and either gender.
  2. Subjects must not have ever worn contact lenses.
  3. Subjects must have normal, healthy eyes.

Exclusion Criteria:

  1. Subjects must not use additional lens cleaners.
  2. subjects must not have any ocular or systemic disease.
  3. Subjects must not have history of ocular surgery/trauma within the last 6 months.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01250925


Locations
United States, Iowa
University of Iowa
Iowa City, Iowa, United States, 52242-1091
United States, Massachusetts
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators
Massachusetts Eye and Ear Infirmary
University of Iowa
Alcon Research
Investigators
Principal Investigator: Pedram Hamrah, MD Massachusetts Eye and Ear Infirmary
Principal Investigator: Christine Sindt, OD University of Iowa
  More Information

Responsible Party: Massachusetts Eye and Ear Infirmary
ClinicalTrials.gov Identifier: NCT01250925     History of Changes
Other Study ID Numbers: 10-04-029
First Submitted: November 29, 2010
First Posted: December 1, 2010
Results First Submitted: April 24, 2013
Results First Posted: January 10, 2017
Last Update Posted: January 10, 2017
Last Verified: April 2013
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Massachusetts Eye and Ear Infirmary:
Contact lens
Lens care

Additional relevant MeSH terms:
Refractive Errors
Eye Diseases